Association between higher BMI and postoperative pain and opioid consumption in pediatric inpatients - A

Barak Cohen1, Marianne A Tanios2, Onur Koyuncu2

  • 1Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Division of Anesthesia, Critical Care, and Pain Management, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Insights

Higher body mass index (BMI) in pediatric surgical patients was not linked to increased postoperative pain. Obese children undergoing surgery did not require more pain medication, challenging previous assumptions about pain management in this group.

Area of Science:

  • Pediatric Surgery
  • Anesthesiology
  • Obesity Research

Background:

  • Childhood and adolescent obesity rates have risen, increasing the number of pediatric surgical patients with obesity.
  • Existing data suggest potential alterations in pain sensitivity and analgesic needs for obese individuals.

Purpose of the Study:

  • To investigate the association between elevated body mass index (BMI) and postoperative pain in pediatric surgical patients.
  • To determine if BMI correlates with increased opioid consumption in the 48 hours following surgery.

Main Methods:

  • Retrospective cohort study of 808 opioid-naïve pediatric patients (8-18 years) undergoing elective non-cardiac surgery.
  • Utilized U.S. CDC weight classifications to assess BMI percentile.
  • Employed multivariable regression models to analyze the relationship between BMI percentile, pain scores, and opioid consumption (mg morphine equivalents/kg).

Main Results:

  • No significant association was found between BMI and postoperative pain for general, orthopedic, or neuro-spinal surgeries.
  • A minor increase in pain (0.07 points per 5 BMI percentile increase) was observed specifically after neuro-cranial surgery.
  • Higher BMI was associated with a significant decrease in postoperative opioid consumption (2.12% per 5 BMI percentile increase).

Conclusions:

  • Higher BMI in pediatric patients (8-18 years) undergoing elective non-cardiac surgery was not clinically associated with increased pain.
  • Contrary to some expectations, elevated BMI did not lead to greater opioid requirements post-surgery.
Abstract

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
770
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
291
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
190
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
831
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
167